Agilent's LC-MS, MS Sales Surge in FYQ1 Atop 16-Percent Drop in Total Revenue, Lay-Offs

Receipts for the firm’s life sciences division, which houses its LC-MS tools, slid 1 percent but company officials said that LC-MS and mass-spec sales experienced double-digit growth.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.